Display options
Cite
Santillán-Urquiza MA, Herrera-Ruiz M, Zamilpa A, et al. . Evid Based Complement Alternat Med. 2019;2019:8404258doi: 10.1155/2019/8404258.
Santillán-Urquiza, M. A., Herrera-Ruiz, M., Zamilpa, A., Jiménez-Ferrer, E., Román-Ramos, R., Alegría-Herrera, E. Y., & Tortoriello, J. (2019). . Evidence-based complementary and alternative medicine : eCAM, 20198404258. https://doi.org/10.1155/2019/8404258
Santillán-Urquiza, Mayra Alejandra, et al. "." Evidence-based complementary and alternative medicine : eCAM vol. 2019 (2019): 8404258. doi: https://doi.org/10.1155/2019/8404258
Santillán-Urquiza MA, Herrera-Ruiz M, Zamilpa A, Jiménez-Ferrer E, Román-Ramos R, Alegría-Herrera EY, Tortoriello J. . Evid Based Complement Alternat Med. 2019 Jul 21;2019:8404258. doi: 10.1155/2019/8404258. eCollection 2019. PMID: 31428176; PMCID: PMC6679897.
Copy Download .nbib Format: NLM
Share it on

Evid Based Complement Alternat Med. 2019 Jul 21;2019:8404258. doi: 10.1155/2019/8404258. eCollection 2019.

[No title available]

Evidence-based complementary and alternative medicine : eCAM

Mayra Alejandra Santillán-Urquiza, Maribel Herrera-Ruiz, Alejandro Zamilpa, Enrique Jiménez-Ferrer, Rubén Román-Ramos, Elian Yuritzi Alegría-Herrera, Jaime Tortoriello

Affiliations

  1. Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social (IMSS), Argentina 1, 62790 Xochitepec, Morelos, Mexico.
  2. Laboratorio de Farmacología, División de Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana (UAM), Mexico City, Mexico.

PMID: 31428176 PMCID: PMC6679897 DOI: 10.1155/2019/8404258

[No abstract available.]

Conflict of interest statement

The authors declare no conflict of interest.

References

  1. Neuropsychobiology. 2001;43(2):83-90 - PubMed
  2. J Pharmacol Exp Ther. 2002 Nov;303(2):805-14 - PubMed
  3. Planta Med. 2003 Jan;69(1):38-43 - PubMed
  4. Psychopharmacology (Berl). 1992;107(2-3):431-6 - PubMed
  5. J Psychiatr Pract. 2001 Jul;7(4):244-6 - PubMed
  6. CNS Drugs. 2005;19 Suppl 1:1-93 - PubMed
  7. Clin Neuropharmacol. 2006 Jan-Feb;29(1):34-44 - PubMed
  8. Psychopharmacology (Berl). 1991;104(1):6-16 - PubMed
  9. Neurology. 2006 Oct 10;67(7):1254-7 - PubMed
  10. Pharmacol Biochem Behav. 2007 Mar;86(3):449-57 - PubMed
  11. Arch Gen Psychiatry. 2007 Jun;64(6):633-47 - PubMed
  12. Neurosci Biobehav Rev. 2008 Jul;32(5):1014-23 - PubMed
  13. Rev Neurol. 2008 Aug 1-15;47(3):137-45 - PubMed
  14. Curr Opin Genet Dev. 2008 Jun;18(3):235-40 - PubMed
  15. Pharmacol Biochem Behav. 2009 Aug;93(2):128-33 - PubMed
  16. Schizophr Bull. 2010 Mar;36(2):246-70 - PubMed
  17. Dis Model Mech. 2010 Jan-Feb;3(1-2):22-6 - PubMed
  18. Eur J Pharmacol. 1978 Feb 15;47(4):379-91 - PubMed
  19. Pharmacol Ther. 2010 Dec;128(3):419-32 - PubMed
  20. Schizophr Bull. 2012 Jan;38(1):9-14 - PubMed
  21. Psychopharmacology (Berl). 2012 May;221(2):249-59 - PubMed
  22. Wien Klin Wochenschr. 2012 Jul;124(13-14):461-3 - PubMed
  23. Curr Top Med Chem. 2013;13(1):26-54 - PubMed
  24. Pharmacol Biochem Behav. 2013 Jul;108:44-53 - PubMed
  25. Front Behav Neurosci. 2014 Mar 06;8:71 - PubMed
  26. Behav Brain Res. 2015 Jan 1;276:130-42 - PubMed
  27. Pharm Biol. 2015;53(12):1850-60 - PubMed
  28. Bosn J Basic Med Sci. 2015 Aug 11;15(3):74-9 - PubMed
  29. Neurosci Lett. 2017 Mar 22;644:37-42 - PubMed
  30. Eur J Pharmacol. 1988 Oct 26;156(1):1-11 - PubMed
  31. Neurotox Res. 2018 Oct;34(3):431-441 - PubMed
  32. Biomed Pharmacother. 2018 Jul;103:879-888 - PubMed
  33. Eur J Pharmacol. 1977 Nov 1;46(1):41-50 - PubMed
  34. Pharmacol Biochem Behav. 1981 May;14(5):741-3 - PubMed
  35. Clin Neuropharmacol. 1993 Jun;16(3):220-36 - PubMed
  36. Am J Psychiatry. 1996 Mar;153(3):321-30 - PubMed

Publication Types